[Federal Register Volume 79, Number 2 (Friday, January 3, 2014)]
[Notices]
[Pages 395-396]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-31478]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-14-0892]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
(404) 639-7570 or send an email to [email protected]. Send written comments 
to CDC Desk Officer, Office of Management and Budget, Washington, DC 
20503 or by fax to (202) 395-5806. Written comments should be received 
within 30 days of this notice.

Proposed Project

    Clostridium difficile Infection (CDI) Surveillance (0920-0892, 
Expiration 07/31/2014)--Extension--National Center for Emerging and 
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    Steady increases in the rate and severity of Clostridium difficile 
infection (CDI) indicate a clear need to conduct longitudinal 
assessments to continue to monitor changes in CDI epidemiology, 
including changes in risk factors for disease, as well as increases in 
incidence and severity of illness related to this pathogen.
    The title and the goals of the project have remained the same since 
the publication of the 60-day Federal Register Notice and there were no 
changes in burden estimates or data collection forms from what is shown 
in the current inventory.
    The surveillance population will consist of persons residing in the 
catchment area of the participating Emerging Infections Program (EIP) 
sites who are 1 year of age or older. This surveillance poses no more 
than minimal risk to the study participants as there will be no 
interventions or modifications to the care study participants receive.
    EIP surveillance personnel will perform active case finding from 
laboratory reports of stool specimens testing positive for C. difficile 
toxin and abstract data on cases using a standardized case report form. 
For a subset of cases (e.g., community-associated C. difficile cases) 
sites will administer a health interview.

[[Page 396]]

    A total of 600 individuals who develop CDI will be contacted for a 
telephone interview annually and, of those, it is estimated that 500 
will meet study inclusion criteria. The interview screening is 
estimated to take 5 minutes and the full telephone interview is 
estimated to take 40 minutes. Therefore, the total estimated annualized 
burden for this data collection is estimated to be 383 hours.
    There are no costs to the respondents other than their time.

                                       Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondents                   Form name           respondents    responses per   response  (in
                                                                                    respondent         hrs.)
----------------------------------------------------------------------------------------------------------------
Persons in the community infected with  Screening Form..........             600               1            5/60
 C. difficile.
                                        Telephone interview.....             500               1           40/60
----------------------------------------------------------------------------------------------------------------


Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2013-31478 Filed 1-2-14; 8:45 am]
BILLING CODE 4163-18-P